title: Potent capillary isotachophoresis (cITP) for analyzing a marker of coronary heart disease risk and electronegative low-density lipoprotein (LDL) in small dense LDL fraction.
abstract: BACKGROUND
  The potency and usefulness of capillary isotachophoresis (cITP) for assessing whole-serum lipoprotein profiles and quantifying electronegative low-density lipoprotein (LDL) has been previously reported.
  
  
  RESULTS
  A new cITP method to measure electronegative LDL in the small dense LDL fraction has been established. Both electronegative LDL and electronegative LDL in the small dense LDL fraction decreased after treatment with fenofibrate.
  
  
  CONCLUSIONS
  This method appears to be useful for analyzing a marker of coronary heart disease risk and may be suitable for evaluating the effects of hypolipidemic agents.
authors.affiliation: Department of Cardiology, Fukuoka University School of Medicine, Japan.
authors.forename: Keita
authors.initials: K
authors.lastname: Noda
authors.forename: Bo
authors.initials: B
authors.lastname: Zhang
authors.forename: Yoshinari
authors.initials: Y
authors.lastname: Uehara
authors.forename: Shin-ichiro
authors.initials: S
authors.lastname: Miura
authors.forename: Akira
authors.initials: A
authors.lastname: Matsunaga
authors.forename: Keijiro
authors.initials: K
authors.lastname: Saku
mesh_terms: D015415:Biomarkers / Q000097:blood; D011232:Chemical Precipitation; D003327:Coronary Disease / Q000175:diagnosis*; D019075:Electrophoresis, Capillary / Q000379:methods*; D011345:Fenofibrate / Q000494:pharmacology / Q000627:therapeutic use; D006493:Heparin; D006801:Humans; D006953:Hyperlipoproteinemia Type IV / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood*; D012306:Risk
chemical_list: D015415:Biomarkers; D008077:Lipoproteins, LDL; D006493:Heparin; D011345:Fenofibrate